Eton Pharmaceuticals Appoints New CFO
Ticker: ETON · Form: 8-K · Filed: Apr 16, 2026 · CIK: 0001710340
Sentiment: neutral
Topics: executive-appointment, cfo, personnel-change
TL;DR
Eton Pharma got a new CFO, filing released 4/16/26.
AI Summary
Eton Pharmaceuticals, Inc. announced on April 16, 2026, the appointment of a new Chief Financial Officer (CFO). The press release, filed as Exhibit 99.1, details this executive change.
Why It Matters
Changes in key executive positions like CFO can signal shifts in financial strategy or operational focus for a company.
Risk Assessment
Risk Level: low — This filing is a routine announcement of an executive appointment and does not contain significant financial or operational disclosures that would inherently increase risk.
Key Players & Entities
- Eton Pharmaceuticals, Inc. (company) — The company making the filing.
- Chief Financial Officer (person) — The position being filled.
- April 16, 2026 (date) — The date of the filing and announcement.
FAQ
Who has been appointed as the new Chief Financial Officer?
The filing does not explicitly name the individual appointed as the new CFO, but it announces the appointment through Exhibit 99.1.
What is the effective date of the CFO appointment?
The filing date is April 16, 2026, and the press release relates to the CFO appointment, implying the appointment is effective around this date.
What other items are included in this 8-K filing?
This 8-K filing includes Item 5.02 (Departure/Election of Officers), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits), with Exhibit 99.1 being a press release about the CFO appointment.
Where is Eton Pharmaceuticals, Inc. located?
Eton Pharmaceuticals, Inc. has its mailing and business address at 21925 W. FIELD PARKWAY SUITE 235 DEER PARK IL 60010-7278.
What is the CIK number for Eton Pharmaceuticals, Inc.?
The CIK number for Eton Pharmaceuticals, Inc. is 0001710340.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 16, 2026 by Chief Financial Officer regarding Eton Pharmaceuticals, Inc. (ETON).